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ABSTRACT 35 
 36 
p53 is an important regulator of cell cycle arrest, senescence, apoptosis and metabolism, and 37 
is frequently mutated in tumours. It functions as a tetramer, where each component dimer 38 
binds to a decameric DNA region known as a response element. We identify p53 binding site 39 
subtypes and examine the functional and evolutionary properties of these subtypes. We start 40 
with over 1700 known binding sites and, with no prior labelling, identify two sets of response 41 
elements by unsupervised clustering. When combined they give rise to three types of p53 42 
binding site. We find that probabilistic and alignment-based assessments of cross-species 43 
conservation show no strong evidence of differential conservation between types of binding 44 
site. In contrast, functional analysis of the genes most proximal to the binding sites provides 45 
strong bioinformatic evidence of functional differentiation between the three types of binding 46 
site. Our results are consistent with recent structural data identifying two conformations of the 47 
L1 loop in the DNA binding domain, suggesting that they reflect biologically meaningful groups 48 
imposed by the p53 protein structure. 49 
 50 
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INTRODUCTION 58 
 59 
The p53 transcription factor is well known for its role in suppressing tumour formation. The wild 60 
type form regulates transcription of genes implicated in cell cycle control, apoptosis and 61 
senescence.1 Common oncogenic p53 mutants either induce a loss of these tumour 62 
suppressor functions or acquire properties that promote cell proliferation, invasion, and 63 
metastasis.2,3 However, it is increasingly recognised that p53 has a plethora of functions 64 
mediated by a wide range of target genes, often with little or no connection to its ‘classical’ 65 
roles in cell cycle control and cell death.4 These functions include metabolic reprogramming, 66 
stem cell maintenance, autophagy, and response to oxidative stress.5,6 There are perhaps 300-67 
3000 functional p53 binding sites in the human genome.7,8,9 p53 binds to these sites as a 68 
homotetrameric ‘dimer of dimers’, where each dimer interacts with a redundant, approximately 69 
palindromic, decameric DNA motif called the p53 response element (RE).10,11,12,13,14 The two 70 
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REs that bind to a full tetramer are either directly adjacent or separated by a few base 71 
pairs.4,15,16 72 
 73 
The best characterised p53 REs are typically found either near the promoters or in the first 74 
introns of target genes17 and are approximately summarized by the 10-base pattern 75 
RRRCWWGYYY15, where ‘R’ indicates A or G, ‘W’ indicates A or T and ‘Y’ indicates C or T. In 76 
the ambiguous positions, not all residues are equally frequent; furthermore, other sequence 77 
variations exist. This flexibility suggests the hypothesis that different types of RE could mediate 78 
different biological processes, regulated by p53 with different binding specificities due to 79 
variable intrinsic sequence affinities,18,19,20 different post-translational modifications, or by 80 
being in complex with different cofactors. Different biological functions might be expected to 81 
be subject to different strengths of natural selection, leading to varying rates of evolution of the 82 
associated REs. Indeed, it has been suggested that REs involved in apoptosis and DNA repair 83 
are more poorly conserved across species than those involved in the cell cycle.21 84 
 85 
Here, we computationally investigate the existence of subsets of p53 binding site. One could 86 
divide p53 binding sites or REs into subsets based on criteria such as Gene Ontology (GO) 87 
annotation of the nearest gene,22 and summarize the properties of these subsets. However, 88 
GO – though an important guideline in broad studies of function – reflects a human-imposed 89 
classification of function, is incomplete, and for intergenic binding sites may involve an arbitrary 90 
decision as to which of the two nearest genes is regulated by the site. Instead of beginning 91 
with GO-based subsets, we begin with the DNA sequences of known binding sites. In an 92 
unsupervised clustering procedure, we classify these on the basis of the sequence similarity 93 
of their constituent decameric REs. This allows groups of binding sites to emerge based on 94 
their sequence, without imposing any limitations based on possible functional consequences. 95 
Our procedure also removes the arbitrary effect of the strand of DNA considered. Once formed 96 
on the basis of sequence similarity, we investigate the function of binding site groups, using 97 
both GO annotation and cross-species conservation, on the assumption that groups differing 98 
in one or both of these respects may have functional significance. 99 
 100 
We use this procedure to group the decameric REs into two clusters, arbitrarily labelled ‘cluster 101 
1’ and ‘cluster 2’. Then, given that two REs form a full p53 binding site, three groups of full 102 
binding site are possible: group ‘1,1’ binding sites, consisting of two REs of cluster 1; group 103 
‘2,2’ binding sites, consisting of two REs of cluster 2; and group ‘1,2’ binding sites, consisting 104 
of one RE of each type. We find evidence of functional differentiation between these binding 105 
site groups, but find no strong evidence of differential evolutionary conservation. 106 
 107 
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 108 
MATERIALS AND METHODS 109 
 110 
Input data 111 
 112 
We obtained 1757 p53 binding sites from the literature, as described by Lim et al.23 These 113 
consist of 327 binding sites from Wei et al.,1 1422 from Smeenk et al.7 after excluding a further 114 
123 also present in Wei et al., and eight from Horvath et al.21. These 1757 binding sites are 115 
given in Supplementary Material. 116 
 117 
Clustering p53 response elements 118 
 119 
Within a binding site, we label as ‘first’ the response element (RE) that is nearer to the start of 120 
the chromosome in the conventional representation; it is thus an arbitrary property of the strand 121 
of the chromosomal sequence being considered. Binding sites were then each split into the 122 
two constituent REs, excluding any spacer. To ensure comparable bases were aligned, the 123 
‘second’ RE was reverse-complemented. All REs were then represented as strings of bases 124 
from the base outermost in the binding site (5’) on the left, to the innermost base (3’) on the 125 
right. Redundant sequences were removed, leaving 1724 unique p53 RE sequences 126 
(Supplementary Material). 127 
 128 
A symmetrical matrix of RE-to-RE Hamming distance was calculated24. Exploratory 129 
hierarchical clustering of this distance matrix with the unweighted paired-groups method using 130 
arithmetic averages (UPGMA)25 produced varying results when repeated, presumably due to 131 
the arbitrary resolution of ties during the clustering procedure26,27. For the final clusters 132 
presented in this paper, we instead clustered using Ward’s method,28 which minimises an 133 
objective function at each stage in the clustering procedure. In typical implementations, the 134 
objective function is within-cluster variance, requiring Euclidian distances as input. Before 135 
clustering, we transformed the RE-to-RE Hamming distance matrix to Euclidian distance using 136 
the ‘lingoes’ function of the ‘ade4’ package29 in R (http://www.r-project.org). Clustering with 137 
Ward’s method was then performed using the ‘hclust’ function of R. 138 
 139 
To divide the REs into subgroups, we drew a phenon line30 on the Ward's method cluster 140 
diagram at a position that split the REs into two sets (i.e. k = 2 clustering). These two primary 141 
clusters of REs represent the most inclusive subsets supported by our analysis. We labelled 142 
these primary clusters of REs as ‘cluster 1’ and ‘cluster 2’. 143 
 144 
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The robustness of the grouping of REs into primary clusters was assessed using a jackknife 145 
procedure. 1000 subsamples (jackknife replicates), each with a random set of 37% REs 146 
omitted,31 were generated from the set of 1724 non-redundant p53 RE sequences. Hence, 147 
each replicate consists of a random subset of 1086 REs (63% of the set of nonredundant REs), 148 
sampled without replacement. Using the same procedure as for the analysis of the set of 1724 149 
non-redundant REs, we clustered REs of each replicate at k = 2. We mapped each of the two 150 
clusters from each replicate to one of the primary clusters from the analysis of the full set of 151 
non-redundant REs. The replicate cluster with the highest proportion of overlap with cluster 1 152 
of the primary clusters was mapped to primary cluster 1, and the other was mapped to primary 153 
cluster 2. As an indication of robustness of the clustering of the 1724 nonredundant REs, a G-154 
test was used to investigate the correspondence between the assignment of REs to primary 155 
clusters in each jackknife replicate, and the assignment to the primary clusters in the analysis 156 
of the full, non-redundant set of 1724 REs. 157 
 158 
To investigate the evolutionary relationships of the primary clusters of RE, position weight-159 
matrices (PWMs) for the RE clusters were compared to known PWMs for p53, p63 and p73 160 
REs from the Transfac database (BioBase Corporation; http://www.biobase-161 
international.com/product/transcription-factor-binding-sites). If presented in Transfac as 162 
counts, binding site PWMs were converted to a frequency representation. Then, frequencies 163 
for each base position within the RE were taken as the mean of the frequencies for the first RE 164 
and for the reverse-complement of the second RE within the binding site. The resulting RE 165 
PWMs represent base frequencies starting from the outermost base of the binding site on the 166 
left (5’) to the innermost base (3’) on the right. PWMs were visualized as logos using Weblogo32 167 
with the nonredundant sequences as input in the case of cluster 1 and cluster 2, and a synthetic 168 
set of 5000 simulated sequences matching the composition of each base position in the RE 169 
PWM in the case of PWMs based on Transfac. Similarities among the innermost 9 bases of 170 
REs (the outermost base was excluded due to its absence in the p73 PWM, M04503), were 171 
quantified using profile-profile alignment scores calculated as the sum of dot-product scores 172 
for the individual base positions33,34 without adjusting for background frequencies. 173 
 174 
Functional and evolutionary analysis of p53 binding site subtypes 175 
 176 
Based on the primary cluster membership of the two constituent REs in the un-jackknifed 177 
cluster analysis, we defined three groups of full p53 binding site. Each binding site may be a 178 
‘1,1’ binding site, consisting of two REs from cluster 1; a ‘2,2’ binding site, consisting of two 179 
REs from cluster 2; or a ‘1,2’ binding site, consisting of one RE from each cluster. In the latter 180 
case, we make no distinction between binding sites in which the RE from cluster 1 comes ‘first’ 181 
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and those in which it comes ‘second’, since this distinction is arbitrary, depending only on which 182 
strand of the double helix is being considered. 183 
 184 
To investigate differential pairing between RE clusters within binding sites, we performed a G-185 
test for evidence of association between ‘cluster 1’ and ‘cluster 2’ REs within the full, redundant 186 
set of 1757 p53 binding sites. 187 
 188 
To test for functional differences between the three groups of binding sites (‘1,1’, ‘1,2’ and ‘2,2’), 189 
nearest genes were assigned to binding sites as described by Lim et al.23 Enrichment for GO 190 
biological process terms was performed with PANTHER35 (http://www.pantherdb.org; version 191 
11.0, released 2016-07-15). To test for overlap with hallmark gene sets, Ensembl Gene 85 IDs 192 
were converted to GRCh38.7 Entrez Gene IDs with Biomart then compared to the 193 
h.all.v5.1.entrez.gmt hallmark gene set in the Molecular Signatures Database36 (MSigDB v5.1, 194 
January 2016 release; http://software.broadinstitute.org/gsea/msigdb/annotate.jsp). 195 
  196 
Conservation levels for the three sets of binding site were first investigated using PhastCons 197 
scores,37 which quantify negative selection by using a hidden Markov model-based method to 198 
estimate the probability that each nucleotide in a multiple alignment forms part of a conserved 199 
sequence element. PhastCons conservations scores take into account the conservation of 200 
neighbouring bases, which makes PhastCons scores a natural choice for detecting stretches 201 
of conserved sequence, such as p53 binding sites. We obtained PhastCons scores which 202 
represent levels of conservation (ranging 0 to 1, where higher values indicate higher 203 
conservation) across the following ten primate species: Homo sapiens (genome assembly 204 
hg19), Pan troglodytes (panTro2), Gorilla gorilla (gorGor1), Pongo abelii (ponAbe2), Macaca 205 
mulatta (rheMac2), Papio hamadryas (papHam1), Callithrix jacchus (calJac1), Tarsius syrichta 206 
(tarSyr1), Microcebus murinus (micMur1), and Otolemur garnetti (otoGar1). The PhastCons 207 
scores for every p53 binding site (as the average across all constituent base pairs within the 208 
site) were extracted using the UCSC table browser function (http://genome.ucsc.edu/cgi-209 
bin/hgTables). For comparison, a background level of conservation was estimated from a pre-210 
calculated, genome-wide phastCons score set downloaded from UCSC 211 
(http://hgdownload.cse.ucsc.edu/goldenpath/hg19/phastCons46way/primates). Random 212 
segments of the human genome, for which PhastCons scores were available, were sampled 213 
with replacement 10,000 times. Lengths of these segments were sampled from an empirical 214 
distribution, estimated from the lengths of the known p53 binding sites. Conservation scores 215 
for the various binding site groups (‘1,1’, ‘1,2’ and ‘2,2’) and the background were compared 216 
using Kruskal-Wallis (KW) tests, a non-parametric equivalent of ANOVA. 217 
 218 
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Secondly, as an additional approach to test binding site conservation, alignments of genomic 219 
regions containing p53 binding sites were extracted using the Ensembl Perl API.38 Genomic 220 
coordinates of p53 binding sites in the three groups were first converted to hg19 coordinates, 221 
and the evolutionary conservation of the binding sites was assessed by calculating average 222 
percentage identities in three types of alignments. The alignments used were, firstly, the LastZ-223 
net39 pairwise alignment of Homo sapiens (GRCh37) versus Pan troglodytes (CHIMP2.1.4); 224 
secondly, the EPO40,41 multiple alignment of six primates (Homo sapiens, Gorilla gorilla, Pan 225 
troglodytes, Pongo abelii, Macaca mulatta, Callithrix jacchus); and thirdly, the EPO alignment 226 
of 15 eutherian mammals (Homo sapiens, Gorilla gorilla, Pan troglodytes, Pongo abelii, 227 
Macaca mulatta, Callithrix jacchus, Mus musculus, Rattus norvegicus, Oryctolagus cuniculus, 228 
Equus caballus, Felis catus, Canis familiaris, Sus scrofa, Bos taurus, Ovis aries). 229 
 230 
Methods are further discussed in the Supplementary Material. 231 
 232 
 233 
RESULTS 234 
 235 
Clusters of p53 response elements and binding sites 236 
 237 
Ward’s method clustering of nonredundant p53 REs based on Euclidian distance led to primary 238 
clusters of size 410 and 1314, which we designate ‘cluster 1’ and ‘cluster 2’, respectively 239 
(Figure 1; Figure 2). 240 
 241 
The spread of results among jackknife replicates is summarized in Table 1. Table 1 shows 242 
very strong evidence of association between the original classification of REs into two clusters 243 
and the classification of REs into two clusters in jackknife replicates. In the majority of jackknife 244 
replicates, REs are assigned to the same primary cluster as in the analysis of the un-jackknifed 245 
set of 1724 nonredundant REs (Figure S1). Hence, the two primary clusters (Figure 1) are 246 
based on a pervasive difference that is present throughout the dataset. 247 
 248 
For the full set of 1757 binding sites, 140 were in group ‘1,1’ (consisting of two REs from cluster 249 
1); 687 were in group ‘1,2’ (consisting of one RE from each cluster); and 930 were in group 250 
‘2,2’ (consisting of two REs from cluster 2). Given the relative sizes of cluster 1 and cluster 2, 251 
these counts are not statistically significantly different from expectations under a null 252 
hypothesis of independent assignment of RE clusters to binding sites (G = 0.689, df = 2, p = 253 
0.709). 254 
 255 
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Comparison of response element clusters with existing PWMs 256 
 257 
When compared to PWMs for REs from known p53, p63 and p73 binding sites derived from 258 
Transfac, our cluster 1 REs are most similar to the p53 RE, then to the p73 RE. Both of our 259 
RE clusters are most similar to the Transfac p53 RE, then to the p73 RE, and least similar to 260 
the p63 RE (Table 2). Cluster 1 and the Transfac-based PWM for the p53 RE show a stronger 261 
CCC homopolymer in the three bases innermost in the binding site than do cluster 2, the p63 262 
RE or the p73 RE (Figure 2). 263 
 264 
Functional analysis of binding site groups 265 
 266 
To identify potential differences in the function of genes near the different classes of binding 267 
site, we measured the overlap with genes defining 50 hallmark biological processes in the 268 
Molecular Signatures Database (MSigDB)36. The hallmark most strongly associated with all 269 
three of our binding site groups was ‘genes involved in p53 pathways and networks’, confirming 270 
the validity of the approach (Table S1). The results for the other hallmarks are shown visually 271 
in Figure 3, with numerical details in Table S1. The main functional difference found between 272 
binding site groups is that group ‘2,2’ is associated with a much broader set of functions. Group 273 
‘1,1’ is mainly associated with signal transduction pathways, particularly pro-survival and 274 
oncogenic pathways. Group ‘1,2’ had an intermediate phenotype, functionally broader than 275 
group ‘1,1’ but not as broad as group ‘2,2’. GO enrichment analysis confirmed that group ‘2,2’ 276 
is associated with a much broader set of functions than the other two groups (Tables S2-S4). 277 
Based on these analyses, we conclude that a switch between ‘1,1’ and ‘2,2’ modes of DNA 278 
binding would change the spectrum of biological functions activated by p53. 279 
 280 
Conservation of binding site groups 281 
The conservation of binding sites in each group was first assessed using PhastCons scores, 282 
which are base-by-base probabilities of a given nucleotide belonging to an evolutionarily 283 
conserved element. The distributions of PhastCons scores for the three classes of binding 284 
sites, as well as the conservation scores across the length-matched genomic background, are 285 
shown in Figure 4. There is no statistically significant difference between conservation scores 286 
across the three groups of binding site (KW X2 = 2.49, df = 2, p = 0.288). Conservation of 287 
binding sites and flanking regions was also assessed (Figure S2). No statistically significant 288 
differences in evolutionary conservation were found when sequences flanking the binding sites 289 
were included by adding 50 base pairs on each side of a binding site (forming ~110 bp regions, 290 
i.e. 100 bp flanking regions; KW X2 = 0.052, df = 2, p = 0.974). Similarly, no statistically 291 
significant difference was found when longer, 1000 bp flanking regions were included (forming 292 
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~1010 bp regions; KW X2 = 1.78, df = 2, p = 0.410). The difference between conservation 293 
scores for all p53 binding sites (mean = 0.176, median = 0.044) and background levels of 294 
genome conservation (mean = 0.127, median = 0.041) was also not statistically significant 295 
(KW X2 = 0.100, df=2, p=0.752). Similarly, no statistically significant differences were found 296 
when separately comparing the conservation of each binding site to the background level of 297 
conservation. 298 
 299 
The distribution of PhastCons conservation scores in both the p53 binding site and genomic 300 
background sequences appears slightly bimodal (Figure 4). The second peak, representing 301 
the highest observed conservation levels, is more pronounced for binding sites than for the 302 
genomic background. We find that 102 binding sites have PhastCons conservation scores 303 
greater than or equal to 0.90, representing 5.9% of all binding sites, but only 195 (2.0%) of 304 
length-matched background genomic regions fall into this highly conserved category. This 305 
constitutes strong evidence that binding sites may have a larger subset of highly conserved 306 
sequences (G-test vs genomic background as an extrinsic null hypothesis; G = 73.45, df = 1, 307 
p < 2.2x10–16). Further examining the highly conserved p53 subset, we find that group ‘1,1’ 308 
sites may be slightly overrepresented. Group ‘1,1’ represents 8.1% of all binding sites, but 309 
constitutes 9.8% of the highly conserved subset, though this difference is not statistically 310 
significant (G-test on 2x2 contingency table; G = 0.42, df = 1, p = 0.52). Applying a less 311 
stringent (but high) conservation score cut-off of 0.8, 141 binding sites (8.2%) are above the 312 
cut-off, compared to the genomic background level of 2.9% (G-test vs extrinsic null hypothesis; 313 
G = 92.34, df = 1, p < 2.2x10–16), and the proportion of the conserved subset included in group 314 
‘1,1’ rises to 12.1%, though this difference remains statistically non-significant (G-test on 2x2 315 
contingency table; G = 2.93, df = 1, p = 0.087). 316 
 317 
The finding of no strong evidence that p53 binding sites are more conserved than background 318 
genomic sequences is in accord with the observation that transcription factor binding sites 319 
show high evolutionary turnover, both in general42 and particularly for p53.21 There was no 320 
strong evidence of a difference in conservation between the functionally broader group ‘2,2’ 321 
and the others (group ‘1,1’ with group ‘1,2’ mean = 0.177, median = 0.046; group ‘2,2’ mean = 322 
0.175, median = 0.041; KW X2 = 0.429, df = 1, p = 0.512).  323 
 324 
As an alternative means to analyse binding site conservation, three sets of multiple alignments 325 
were examined to study p53 binding site sequence divergence over increasingly long spans 326 
of evolutionary time (chimp-human, primate, and eutherian mammal; Figure S3). 327 
Overwhelmingly, these alignments support the PhastCons-based conclusion of no differential 328 
conservation between binding site groups (Table 3). The sole conservation differences close 329 
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to the conventional cut-off for statistical significance for a single test (p < 0.05) occur in the 330 
chimp-human comparison: group ‘1,1’ binding sites are more highly conserved between 331 
humans and chimps than both group ‘1,2’ (p = 0.051) and group ‘2,2’ (p = 0.040; Table 3). This 332 
may be taken as weak evidence for the conservation of group ‘1,1’ p53 binding site functionality 333 
between chimps and humans, or equivalently, the relative divergence of p53 binding sites 334 
related to non-canonical functions (i.e. those containing cluster 2 REs). However, the statistical 335 
significance is borderline and may be misleading due to multiple testing. Higher conservation 336 
of group ‘1,1’ binding sites was not observed in the primate alignments or in the mammal 337 
alignments (Table 3).  338 
 339 
 340 
DISCUSSION 341 
 342 
We have shown that subtle differences in p53 binding site functionality can be identified by 343 
clustering the constituent decamers on the basis of sequence similarity. We obtained a robust 344 
grouping of decamers into two major clusters. These two clusters of decamers can give rise to 345 
three groups of binding site, each composed of one of the three possible combinations of 346 
decamer. The frequencies of specific pairings of decamers from the two clusters into binding 347 
sites show no strong difference compared to random expectation, and we find no appreciable 348 
difference in conservation compared to background genome conservation levels. Furthermore, 349 
the three binding site groups also showed little evidence of differential conservation between 350 
themselves, with the strongest evidence hinting at relatively strong chimp/human conservation 351 
of group ‘1,1’ binding sites, though with only borderline statistical significance. However, we 352 
find that genes near ‘2,2’ sites have a much broader range of functions than genes near ‘1,1’ 353 
and ‘1,2’ sites, (Figure 3 and Tables S1-S4). Combined with the robustness of the RE clusters 354 
demonstrated by jacknifing, and with results from earlier studies (discussed below), we 355 
conclude that switching p53 from a '1,1' to a '2,2' mode of binding would substantially change 356 
the functional consequences of p53 activation. 357 
 358 
Our results confirm a long-standing suspicion that p53 binding sites are not simply duplicated 359 
copies of a symmetrical RRRCWWGYYY decamer. Instead, the REs in cluster 1 are C-rich in 360 
the final three positions, which correspond to the innermost positions in the middle of a full 361 
20mer (or larger) binding site. Because of the way we report the decamer sequences, ‘1,1’ 362 
binding sites will tend to have the sequence ‘CCCGGG’ at the centre of the 20mer. This is the 363 
sequence that was found in the original SELEX study that first defined the p53 binding site.43 364 
Shortly thereafter we showed that mutations in the L1 loop alter the affinity and specificity of 365 
DNA binding,18 but an understanding of the mechanism had to wait until the Halazonetis group 366 
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discovered that the L1 loop in C. elegans p53 contains a small alpha helix.11 They went on to 367 
show that the L1 loop in human p53 can form the same alpha helix.44 The lysine 120 DNA 368 
contact residue lies at the tip of the loop. Accordingly, formation of the alpha helix retracts the 369 
lysine from the DNA. The discovery that the L1 loop can adopt two different conformations 370 
immediately suggests an explanation for the asymmetry in the cluster 1 and cluster 2 371 
sequences in our study. The L1 loop is in the retracted form in the outer p53 subunits in the 372 
tetramer.44,45, 46 In this form lysine 120 can not reach into the major groove to contact the bases, 373 
so the sequence is less constrained. In contrast, the loop is in the extended form in the inner 374 
two subunits, allowing lysine 120 to forms hydrogen bonds with the bases in the major groove. 375 
The hydrogen bonds between the side chains of lysine 120, cysteine 277 and arginine 280 376 
and the DNA are shown as yellow dotted lines in Figure 5A. The L1 loop is shown in the 377 
extended form in Figure 5B, and in the retracted state in Figure 5C. Switching to the extended 378 
conformation allows induced fitting of the protein to the DNA when the correct sequence is 379 
present.44,45 It is likely that the L1 loop adopts many different conformations while searching 380 
for the correct sequence and that, thanks to induced fitting, this leads to important differences 381 
in the kinetics of binding that depend on the sequence.44,45 In addition to the inner-outer 382 
asymmetry caused by changes in the conformation of the L1 loop there are differences 383 
between the hydrogen bonds formed, depending on the exact sequence at positions 8 and 9 384 
in the decamer: cysteine 277 forms a hydrogen bond with either O4 of thymine or N4 of 385 
cytosine at position 8; lysine 120 forms hydrogen bonds with N7 and O6 of guanine but only 386 
N7 of adenine at position 9; and hydrophobic and van de Waals forces from alanine 276 and 387 
cysteine 277 stabilise the C5 methyl group in T at position 8.10,44,45 Taken together, these data 388 
would lead us to expect p53 to bind with decreasing affinity to ‘1,1’, '1,2', and '2,2' sites. 389 
Hallmark analysis reveals a preference for prosurvival and oncogenic signalling pathways for 390 
‘1,1’ sites (Figure 3). This is consistent with old suggestions that p53 promotes survival early 391 
after activation, and only binds to all of its targets if the signal persists and p53 accumulates. 392 
Originally this was interpreted as a binary switch between cell cycle arrest and apoptotic sites, 393 
with the latter containing only a single decamer18,20 and having a lower affinity for p53 20,19, but 394 
the multiplication of p53 functions over time means the effects are likely to be more diverse 395 
and to depend heavily on the cellular context. The most important DNA binding residue in p53 396 
is arginine 280, which forms hydrogen bonds with the G base paired to the invariant C at 397 
position 4 in the pentamer. The corresponding positions in the decamer are 4 (C) and 7 (G). 398 
The pattern in cluster 1, with a stronger preference for G at position 7 than for C at position 4, 399 
is reminiscent of a binding site profile identified by Veprintsev and Fersht.8 Interestingly, 400 
acetylation of lysine 120 47,48 negated the difference.49 In addition to acetylation of K120, the 401 
cell can manipulate the sequence specificity of p53 through multiple mechanisms, for example 402 
binding to Hzf and ASPP proteins.50,51 Indeed, many publications have described plausible 403 
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regulatory mechanisms based on post-translational modifications and protein-protein 404 
interactions (reviewed by Carvajal and Manfredi52) that could explain the differences we have 405 
found by clustering of p53 binding sites. Given the elegant structural studies from the 406 
Halazonetis group cited above, we suspect that these regulatory mechanisms converge on the 407 
L1 loop and switch p53 from a ‘1,1’ to a ‘2,2’ mode of binding.  408 
 409 
In conclusion, we have shown that p53 binding sites can be classified into groups that may 410 
reflect the different modes of DNA binding that have been described in structural studies. 411 
Integration of sequence-based clustering with data on post-translational modification, cofactor 412 
binding and changes in the structure of the DNA binding domain is a promising direction for 413 
future research. 414 
 415 
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TABLES 597 
 598 
 599 
Table 1. Contingency table showing the relationship between response element (RE) 600 
classification in the original cluster analysis (Figure 1) and re-classification in jackknife 601 
replicates. A highly statistically significant association was observed between the original 602 
classification of REs into two clusters and the classification of REs into two clusters in jackknife 603 
replicates (G = 519.98, d.f. = 1, p < 2.2x10-16).  604 
 605 
Counts Replicate cluster 1 Replicate cluster 2 Totals 
Original cluster 1 440 70 510 
Original cluster 2 344 870 1214 
Totals 784 940 n = 1724 
 606 
 607 
Table 2. Dot-product alignment scores between PWMs for RE cluster 1, RE cluster 2, and 608 
PWMs for the p53 RE, p63 RE and p73 RE derived from the Transfac database (M01651, 609 
M07138 and M04503). To match the PWM for p73, which has REs of length 9, the first 610 
(outermost) base of the other PWMs was omitted. The alignment score depends both on the 611 
extent of matching between profiles and the extent of ambiguity within profiles, and is not a 612 
metric. Scores are symmetrical and are only given for the bottom-left portion of the table. 613 
Scores can range from a maximum of 9, for two unambiguous 9-base PWMs which perfectly 614 
match, to a minimum of 0. 615 
 616 
 Cluster 1 Cluster 2 p53 Transfac p63 Transfac p73 Transfac 
Cluster 1 4.8 . . . . 
Cluster 2 4.3 4.7 . . . 
p53 Transfac 4.9 5 5.5 . . 
p63 Transfac 4.3 4.5 4.8 4.5 . 
p73 Transfac 4.5 4.9 5.3 4.7 5.3 
 617 
 618 
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Table 3. p53 binding site conservation as judged by averaged percentage identities from 619 
multiple sequence alignments. In each alignment, the mean and median percentage identities 620 
for the three binding site groups are shown. The distribution of percentage identities in each 621 
binding site group was pairwise tested against the remaining 2 groups (X2 = Kruskal-Wallis X2 622 
statistic; p = p value). 623 
 624 
 Binding site Mean Median Group ‘1,1’ Group ‘1,2’  
Chimp-
human 
divergence 
Group ‘1,1’ 99.18 100 . . 
Group ‘1,2’ 98.70 100 X2 = 3.82, p = 0.051 . 
Group ‘2,2’ 98.60 100 X2 = 4.21, p = 0.040 X2 = 0.03, p = 0.866 
Primate 
divergence 
Group ‘1,1’ 93.73 95 . . 
Group ‘1,2’ 92.07 95 X2 = 0.85, p = 0.358 . 
Group ‘2,2’ 92.46 95 X2 = 0.97, p = 0.325 X2 = 0.007, p = 0.935 
Eutherian 
mammal 
divergence 
Group ‘1,1’ 82.52 82.37 . . 
Group ‘1,2’ 82.72 83.30 X2 = 0.21 p = 0.645 . 
Group ‘2,2’ 82.41 82.41 X2 = 0.04, p = 0.842 X2 = 1.56, p = 0.221 
 625 
  626 
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FIGURE CAPTIONS 627 
 628 
Figure 1. Summary of dendogram obtained by cluster analysis of the 1724 nonredundant 629 
decamers. For visualization purposes, an arbitrary phenon line was drawn at a height of 38. 630 
The number of sequences in each resulting sub-cluster is shown, along with the logo 631 
summarizing those sequences, with bases ranging from 1 (outermost) to 10 (innermost) in the 632 
binding site. The logo y-axis represents information content, with ticks at 1 and 2 bits. The full 633 
dendogram is available as a file in Newick format in the Supplementary Material. 634 
 635 
Figure 2. Sequence logos for (a) cluster 1 REs, (b) cluster 2 REs, (c) p53 Transfac RE, (d) p63 636 
Transfac RE and (e) p73 Transfac RE. Bases range from 1 (outermost) to 9 or 10 (innermost) 637 
in the binding site. (c), (d) and (e) are based on Transfac M01651, M07138 and M04503, 638 
respectively. 639 
 640 
Figure 3. Functional enrichment for hallmark biological processes. The genes nearest to the 641 
binding sites were used to create putative target gene lists for each group. The bars in the 642 
figure show the relative enrichment for genes in each hallmark; the dots show the p-value 643 
expressed as -log10. Only hallmarks for which at least one group gave p < 0.0001 are shown; 644 
within each hallmark missing bars correspond to associations with p > 0.01. For numerical 645 
details see Table S1. The terms in MSigDB corresponding to the labels are: PI3K, 646 
PI3K_AKT_mTOR_signaling; NFKB, TNFA_signaling_via_NFKB; Hyp, hypoxia; TOR, 647 
mTORC1_signaling; RAS, KRAS_signaling_up; UV, UV_response_down; Apo, apoptosis; 648 
EMT, epithelial_mesenchymal_transition; ER, estrogen_response_early; Inf, 649 
inflammatory_response; Myo, myogenesis; Gly, glycolysis; IL2, IL2_STAT5_signaling; Xeno, 650 
xenobiotic_metabolism. 651 
 652 
Figure 4. Histograms of PhastCons evolutionary conservation scores for binding sites in our 653 
p53 binding site group ‘1,1’ (n = 140), group ‘1,2’ (n = 687), group ‘2,2’ (n = 930) and the 654 
genomic background (n = 10,000), across 10 species of primates. Dashed lines indicate means 655 
for each group. 656 
 657 
Figure 5. p53 DNA binding. (A) The p53 loop-sheet-helix is shown in contact with the major 658 
groove of the DNA. Amino acid 120K (cyan) binds to G on the Watson strand; 277C (orange) 659 
binds to T and 280R (red) to G on the Crick strand. Amino acid 120K arises from the tip of the 660 
L1 loop (the green line at the bottom of the figure). Hydrogen bonds are shown as dotted yellow 661 
lines. (B) The L1 loop in the extended form, as in panel (A). (C) The L1 loop in the retracted 662 
 21 
form. The figures were made with PyMOL (Schrödinger, LLC) from PDB structure 3Q05; for a 663 
detailed description of the p53 DNA-protein interaction see 44,45,46. 664 
0 
1 
2 
104 
72 
100 
88 
146 
112 
160 
131 
69 
95 
54 
115 
131 
47 
 97 
 66 
137 
Cluster 1 
Cluster 2 
0 
1 
2 
0 
1 
2 
0 
1 
2 
0 
1 
2 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
0 
1 
2 
0 
1 
2 
 
1 
0 
1 
2 
     1  2  3  4 5  6 7  8  9 10  
    80                       60                       40                        20                        0   
(A) Cluster 1
(B) Cluster 2
(C) p53 (Transfac)
(D) p63
(E) p73
weblogo.berkeley.edu
0
1
2
bi
ts
5′
1T
A
G
2C
A
T
G
3T
G
A
4A
G
T
C
5G
C
T
A
6C
G
A
T
7A
C
T
G
8A
T
C
9A
T
C
10
G
A
T
C
3′
weblogo.berkeley.edu
0
1
2
bi
ts
5′
1
A
G
2T
A
G
3T
G
A
4A
G
T
C
5C
G
T
A
6G
A
T
7
A
T
G
8A
C
T
9A
T
C
10
A
T
C
3′
weblogo.berkeley.edu
0
1
2
bi
ts
5′
1
T
A
G
2T
A
G
3T
G
A
4T
C
5G
T
A
6G
A
T
7
G
8A
C
T
9A
T
C
10
A
T
C
3′
weblogo.berkeley.edu
0
1
2
bi
ts
5′
1
G
A
2T
A
G
3T
A
G
4T
C
5G
T
C
A
6G
A
T
7
G
8A
C
T
9GA
T
C
10
T
C
3′
weblogo.berkeley.edu
0
1
2
bi
ts
5′
1
A
T
G
2
T
G
A
3
C
4
G
A
5
G
A
T
6
G
7
A
C
T
8G
A
T
C
9
3′
0
5
10
15
20
PI3K NFKB Hyp  TOR   RAS   UV   Apo   EMT    ER    Inf    Myo   Gly   IL2   Xeno  
B
ar
s:
 re
la
tiv
e 
en
ric
hm
en
t. 
D
ot
s:
 -l
og
10
 p
-v
al
ue
group 1,1
group 1,2
group 2,2
010
20
30
0.00 0.25 0.50 0.75 1.00
Fr
eq
ue
nc
y
Group 1,1 Conservation
0
50
100
150
200
0.00 0.25 0.50 0.75 1.00
Fr
eq
ue
nc
y
Group 1,2 Conservation
0
100
200
300
0.00 0.25 0.50 0.75 1.00
Fr
eq
ue
nc
y
Group 2,2 Conservation
0
1000
2000
3000
0.00 0.25 0.50 0.75 1.00
Fr
eq
ue
nc
y
Background Conservation
Averaged PhastCons 
Score for Site
Averaged PhastCons 
Score for Site
Averaged PhastCons 
Score for Site
Averaged PhastCons 
Score for Site
AB
C
